Inhibitory Antibodies
| Product Name | CAS No. | Specification | Application | Registration |
| Aflibercept | 862111-32-8 | 95+% | ||
| Anakinra (IL-1Ra) | 143090-92-0 | 98+% | Rheumatoid Arthritis | |
| Trastuzumab (anti-HER2) | 180288-69-1 | 95+% | Antineoplastic Agent | |
| Cetuximab (C225) | 205923-56-4 | 95+% | Antineoplastic Agent | |
| Etanercept | 185243-69-0 | 95+% |
Products
- All
- Pharmaceutical Intermediates
- Active Pharmaceutical Ingredients
- Drug Impurities & Metabolites
- Novel Life Science Reagents
- Signaling Pathways
- Inhibitory Antibodies
- Bioactive Small Molecules
- Screening Compounds
- Stable Isotope Labelled Compounds
- COVID-19 Related Inhibitors
- Amino Acids & Vitamins
- Natural Products
- Health & Nutritional Ingredients
- Pharmaceutical Excipients
- Specialty Chemicals & Building Blocks
Custom Synthesis-High Value-Added Advanced Pharmaceutical Intermediates
E-Mail: sales (at)Chemleader.com.cn
E-Mail: sales (at)Chemleader.com.cn